Expert Review of Anti-Infective Therapy

Article	Citations
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	98
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	77
Neonatal ocular prophylaxis in the United States: is it still necessary?	69
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	63
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	61
Challenges in preserving antibiotic effectiveness: time for a novel approach	51
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	46
Visceral leishmaniasis elimination in India: progress and the road ahead	39
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	39
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	39
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	39
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	34
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	33
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	33
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	28
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	26
Identifying predictors of treatment failure with community-acquired pneumonia: an update	26
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	25
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	24
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	23
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	22
Treatment of vaginitis caused by non-albicans Candida species	22
Reemergence of monkeypox: prevention and management	22

All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	21
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	21
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections	20
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?	20
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	19
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	18
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective	18
Diagnostic and clinical management of Candida auris infections in immunocompromised patients	18
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases	17
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges	17
Infliximab as a potential treatment for COVID-19	17
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review	17
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies	16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	16
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta	15
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures	15
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance	15
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges	15
Diagnostic and management strategies for chronic hepatitis E infection	14
Diagnosing fungal infections in clinical practice: a narrative review	14
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	14
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases	14
Statement of Retraction	14
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19	14
Correction	14
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India	14
The serological dilemma: rethinking syphilis treatment evaluation	13
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?	13
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential	13
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae	13
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections	13
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review	13
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	12
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches	12
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	12
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	12
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat	12
Challenges associated with pertussis detection, monitoring, and vaccination in adults	11
Monoclonal antibodies for the treatment of COVID-19 infection in children	11
The evolving debate around screening for Chlamydia trachomatis	11
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	11
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	11
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea	11
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	11
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	11
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	11
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	11
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	10
How can we tackle the overuse of antibiotics in low- and middle-income countries?	10
Gram-positive infections in special populations. Expert view on the role of dalbavancin	10

Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	10
New insights into the treatment of acute otitis media	10
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study	10
Tocilizumab for the treatment of COVID-19	9
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients	9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	9
How do we best manage Clostridioides difficle infections in the elderly?	9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	9
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	9
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	9
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	9
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	9
Now that griseofulvin is not available, what to do with tinea capitis treatments?	9
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	9
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	8
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	8
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	8
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	8
Past, present, and future perspectives on aztreonam and avibactam	8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	8
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak	8
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	8
Artificial intelligence and prescription of antibiotic therapy: present and future	8
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis	8
An update on newer antifungals	8
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection	8
A systems thinking approach for antimicrobial stewardship in primary care	8
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	8
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance	8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	8
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study	8
Global importance of new treatment strategies to efforts to control hepatitis B virus	8
Strengths and caveats of identifying resistance genes from whole genome sequencing data	8
Ivermectin: a pathway out of the pandemic or another dead end?	8
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis	7
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis	7
Containment strategies for COVID-19 in India: lessons from the second wave	7
Host defense mechanisms against Candida auris	7
Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review	7
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV	7
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon	7
Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection	6
The war against bacteria, from the past to present and beyond	6
HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity	6
Can probiotics replace antibiotics? Not yet, says the evidence	6
Brucellosis control methods with an emphasis on vaccination: a systematic review	6
Non-cancerous complications in HTLV-1 carriers	6
An update on antimicrobial selection and duration for intra-abdominal infections	6
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	6
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	6
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis	6
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	6
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?	6
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta	6
The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis	6
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow	6
Brincidofovir in the Era of Mpox	6
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China	6
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	5
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	5
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	5
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	5
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	5
Gram-negative blood stream infections: prospects and challenges of rapid antimicrobial susceptibility testing	5
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	5
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	5
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	5
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	5
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	5
Candida auris biofilm: a review on model to mechanism conservation	5
Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	5
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	5
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	5
How do we change our approach to COVID with the changing face of disease?	5
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?	5
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	5

Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	5
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	5
Artificial intelligence and its application in clinical microbiology	5
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	5
Omadacycline in treating community-based infections: a review and expert perspective	5
From guesswork to guidelines: advancing diagnostic stewardship in immunocompromised hosts	5
Langya henipavirus outbreak	5
Genomic surveillance of Neisseria gonorrhoeae : a crucial tool in the global fight against antimicrobial resistance	5
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	5
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	5
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system	5
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	5
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	5
False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews	4
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	4
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	4
Personalized care approaches to hepatitis C therapy: recent advances and future directions	4
Assessment of rationality of available fixed dose combinations of antibiotics in India	4
Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis	4
Therapeutic strategies to address monkeypox	4
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	4
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	4
Antimicrobial management of complex biofilms in diabetic foot ulcers: a microbiological perspective	4
Antibiotic resistance in low- and middle-income countries: current practices and its global implications	4
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution	4
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges	4
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	4
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis	4
Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States	4
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	4
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis	4
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis	4
Biosimilars as antivirals: opportunities and challenges	4
Managing sepsis in the era of precision medicine: challenges and opportunities	4
Nirmatrelvir/ritonavir: real world drug–drug interaction management experience	4
Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis	4
Letter to the Editor: the earliest observation of bla NDM was in Israel	4
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis	4
Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice	4
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials	4
Immunocompromised patients and COVID-19: how do we protect those most at risk?	4
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants	4
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway	4
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	4
Secnidazole: a treatment for trichomoniasis in adolescents and adults	4
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence	4
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	4
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials	4
Letter to the editor: “real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients”	4
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	3
Updates in the clinical management of tuberculous meningitis	3
Doxycycline post-exposure prophylaxis as prevention of STIs – the golden bullet?	3
Interventions to improve outcomes in community-acquired pneumonia	3
Ceftobiprole medocaril for the treatment of pneumonia	3
Challenges and controversies of urinary tract infection treatment in kidney transplant recipients	3
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	3
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment	3
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	3
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	3
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	3
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	3
The antifungal pipeline for invasive fungal diseases: what does the future hold?	3
Penile microbiomes have important implications for HIV susceptibility and broader reproductive health	3
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review	3
The impact of COVID-19 on the HIV continuum of care: challenges, innovations, and opportunities	3
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults	3
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences	3
Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies	3
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	3
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance	3
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	3
From Data to Decisions: Leveraging Large, Real-World Databases to Guide Clinical Practice in C. difficile Infections	3
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	3
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	3
Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	3
Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis	3
Fighting with brain-eating amoeba: challenges and new insights to open a road for the treatment of Naegleria fowleri infection	3
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis	3
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities	3
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications	3
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?	3
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?	3
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	3